• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

霍奇金淋巴瘤治疗与后续乳腺癌雌激素受体状态的关联。

Association of Treatment for Hodgkin Lymphoma With Estrogen Receptor Status of Subsequent Breast Cancers.

机构信息

Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.

出版信息

JAMA Oncol. 2018 Mar 1;4(3):414-416. doi: 10.1001/jamaoncol.2017.4887.

DOI:10.1001/jamaoncol.2017.4887
PMID:29346498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5885823/
Abstract

This population-based cohort study examines the association of radiotherapy for Hodgkin lymphoma with risk of ER-positive and ER-negative breast cancers using data from the US National Cancer Institute Surveillance, Epidemiology, and End Results database.

摘要

这项基于人群的队列研究使用美国国家癌症研究所监测、流行病学和最终结果数据库的数据，研究了霍奇金淋巴瘤的放射治疗与 ER 阳性和 ER 阴性乳腺癌风险的相关性。

相似文献

1
Association of Treatment for Hodgkin Lymphoma With Estrogen Receptor Status of Subsequent Breast Cancers.霍奇金淋巴瘤治疗与后续乳腺癌雌激素受体状态的关联。
JAMA Oncol. 2018 Mar 1;4(3):414-416. doi: 10.1001/jamaoncol.2017.4887.
2
Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.接受霍奇金淋巴瘤治疗的年轻女性的累积绝对乳腺癌风险。
J Natl Cancer Inst. 2005 Oct 5;97(19):1428-37. doi: 10.1093/jnci/dji290.
3
Variation in the risk of radiation-related contralateral breast cancer by histology and estrogen receptor expression in SEER.SEER 中组织学和雌激素受体表达对放射相关对侧乳腺癌风险的变化。
Breast Cancer Res Treat. 2012 Feb;131(3):1021-7. doi: 10.1007/s10549-011-1820-8. Epub 2011 Oct 21.
4
Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.接受过霍奇金淋巴瘤放疗的女性所患乳腺癌的临床病理特征：一项基于人群队列的研究结果
Cancer. 2022 Apr 1;128(7):1365-1372. doi: 10.1002/cncr.34065. Epub 2021 Dec 17.
5
Late effects of treatment for childhood Hodgkin's disease.
N Engl J Med. 1996 Aug 1;335(5):352-3.
6
High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors.长期霍奇金淋巴瘤幸存者的后续恶性肿瘤和心血管疾病负担高。
Br J Cancer. 2018 Mar 20;118(6):887-895. doi: 10.1038/bjc.2017.476. Epub 2018 Jan 30.
7
Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy.根据接受放疗的霍奇金淋巴瘤长期生存者的临床病理特征，乳腺癌发病风险。
Br J Cancer. 2010 Sep 28;103(7):1081-4. doi: 10.1038/sj.bjc.6605877. Epub 2010 Sep 14.
8
Breast cancer after Hodgkin disease: hope for a safer cure.
JAMA. 2003 Jul 23;290(4):529-31. doi: 10.1001/jama.290.4.529.
9
Hormone receptor status of contralateral breast cancers: analysis of data from the US SEER population-based registries.对侧乳腺癌的激素受体状态：来自美国基于监测、流行病学和最终结果（SEER）人群登记处数据的分析
Breast Cancer. 2017 May;24(3):400-410. doi: 10.1007/s12282-016-0716-1. Epub 2016 Aug 8.
10
Incidence of breast cancer among female survivors of Hodgkin lymphoma: a US-population-based trend analysis from 1973 to 2011.霍奇金淋巴瘤女性幸存者中乳腺癌的发病率：一项基于美国人群的1973年至2011年趋势分析。
Blood. 2015 Oct 8;126(15):1861-3. doi: 10.1182/blood-2015-05-647412. Epub 2015 Aug 17.

引用本文的文献

1
Role of estrogen receptor signaling pathway-related genes in diffuse large B-cell lymphoma and identification of key targets integrated bioinformatics analysis and experimental validation.雌激素受体信号通路相关基因在弥漫性大B细胞淋巴瘤中的作用及关键靶点的鉴定：综合生物信息学分析与实验验证
Front Oncol. 2022 Nov 29;12:1029998. doi: 10.3389/fonc.2022.1029998. eCollection 2022.
2
Health Benefits and Cost-Effectiveness of Children's Oncology Group Breast Cancer Screening Guidelines for Chest-Irradiated Hodgkin Lymphoma Survivors.儿童肿瘤学组胸部放疗霍奇金淋巴瘤幸存者乳腺癌筛查指南的健康获益和成本效益。
J Clin Oncol. 2023 Feb 10;41(5):1046-1058. doi: 10.1200/JCO.22.00574. Epub 2022 Oct 20.
3
Treatment-related peripheral small cell lung carcinoma in a Hodgkin lymphoma survivor.霍奇金淋巴瘤幸存者发生治疗相关的外周性小细胞肺癌。
BMJ Case Rep. 2022 Mar 9;15(3):e249104. doi: 10.1136/bcr-2022-249104.

本文引用的文献

1
Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study.儿童癌症幸存者中无胸部放射治疗史的乳腺癌风险：来自儿童癌症幸存者研究的报告。
J Clin Oncol. 2016 Mar 20;34(9):910-8. doi: 10.1200/JCO.2015.62.3314. Epub 2015 Dec 23.
2
Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study.霍奇金淋巴瘤化疗后的二次癌症风险：一项英国协作队列研究。
J Clin Oncol. 2011 Nov 1;29(31):4096-104. doi: 10.1200/JCO.2011.34.8268. Epub 2011 Oct 3.
3
Radiation dose and breast cancer risk in the childhood cancer survivor study.儿童癌症幸存者研究中的辐射剂量与乳腺癌风险
J Clin Oncol. 2009 Aug 20;27(24):3901-7. doi: 10.1200/JCO.2008.20.7738. Epub 2009 Jul 20.
4
Solid cancer incidence in atomic bomb survivors: 1958-1998.原子弹爆炸幸存者实体癌发病率：1958 - 1998年
Radiat Res. 2007 Jul;168(1):1-64. doi: 10.1667/RR0763.1.
5
Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.接受霍奇金淋巴瘤治疗的年轻女性的累积绝对乳腺癌风险。
J Natl Cancer Inst. 2005 Oct 5;97(19):1428-37. doi: 10.1093/jnci/dji290.
6
Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.霍奇金病年轻女性放疗和化疗后的乳腺癌
JAMA. 2003 Jul 23;290(4):465-75. doi: 10.1001/jama.290.4.465.